Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Synthomer plc (LSE:SYNT) has successfully completed the sale of its subsidiary, William Blythe Limited, for £30 million. After transaction costs, the company received net cash proceeds of £25 million, which have been applied to reduce overall Group debt. This divestment aligns with Synthomer’s strategic focus on refining its core operations and improving financial resilience.
Although Synthomer continues to face challenges from weak financial performance that negatively affect its outlook, there are some encouraging technical signals. The company’s valuation remains pressured due to ongoing negative earnings, but recent strategic moves like this divestment suggest a pathway toward future financial improvement.
More about Synthomer
Synthomer plc is a prominent supplier of specialized polymers and chemical ingredients, serving sectors including coatings, construction, adhesives, and health and protection. Headquartered in London, the company operates 29 manufacturing facilities worldwide, spanning Europe, North America, the Middle East, and Asia. With a strong commitment to sustainability and innovation, Synthomer partners with customers to develop new and improved products, with a significant portion of its revenue generated from patent-protected innovations.
